Drug Trial Radar · NCT07120503
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Jul 24, 2025
Primary completion
Oct 1, 2028
Study completion Nov 23, 2028
Sponsor
- Lead sponsor
- Windward BioIndustry
- Sponsor type
- Industry
- First posted
- Aug 13, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a global Phase 2 study divided in two parts. Part A is a double-blind, randomized dose-range finding study in adults with moderate to severe asthma to confirm the dosing regimen of WIN378 that can be tested in future pivotal trials for efficacy and safety. Part B is a pivotal double-blind, randomized study to demonstrate the efficacy and safety of WIN378 in adults with severe uncontrolled asthma. Two dose levels of WIN378 will be tested against placebo to evaluate AAER, lung function, asthma control, asthma-related quality of life and other important efficacy endpoints.
Conditions
- Asthma
Interventions
WIN378Drug
WIN378 is a fully human, ultra-long-acting monoclonal antibody given twice-yearly that binds to thymic stromal lymphopoietin (TSLP), blocking its activity and thereby reducing airway inflammation and improving asthma control over the extended dosing interval.
PlaceboDrug
A sham injection consisting of placebo to mask WIN378.
Primary outcomes
What the sponsor says the trial is designed to measure.
- PART A: Number of participants with treatment-emergent adverse events (TEAEs) during the studyTime frame: Week 0 - Week 60
- PART A: Number of participants with treatment-emergent serious adverse events (TESAEs) during the studyTime frame: Week 0 - Week 60
- PART A: Number of participants with abnormal vital signs during the studyTime frame: Week 0 - Week 60
- PART A: Number of participants with abnormal laboratory assessments during the studyTime frame: Week 0 - Week 60
- PART A: Number of participants with Clinically significant abnormal ECG results during the studyTime frame: Week 0 - Week 60
- PART A: WIN 378 Pharmacokinetics: concentration at trough [Ctrough]Time frame: Week 0 - Week 60
- PART A: WIN 378 Pharmacokinetics: area under the concentration time curve [AUC]Time frame: Week 0 - Week 60
- PART A: WIN 378 Pharmacokinetics: maximum observed concentration [Cmax])Time frame: Week 0 - Week 60
- PART A: Number of participants with positive anti-drug antibodies (ADA) during the studyTime frame: Week 0 - Week 60
- PART B: Annualized Asthma Exacerbation Rate (AAER)Time frame: 24 Weeks after last dose
Locations
73 sites in 8 countries. Site status is shown where the registry gives one.
WB Contracted Clinical Research Site
Los Angeles, California · Active not recruiting
WB Contracted Clinical Research Site
San Jose, California · Active not recruiting
WB Contracted Clinical Research Site
Melbourne, Florida · Recruiting
WB Contracted Clinical Research Site
Miami, Florida · Active not recruiting
WB Contracted Clinical Research Site
White Marsh, Maryland · Active not recruiting
WB Contracted Clinical Research Site
Stow, Massachusetts · Active not recruiting
WB Contracted Clinical Research Site
Detroit, Michigan · Active not recruiting
WB Contracted Clinical Research Site
Richfield, Minnesota · Active not recruiting
WB Contracted Clinical Research Site
St Louis, Missouri · Active not recruiting
WB Contracted Clinical Research Site
Bellevue, Nebraska · Active not recruiting
WB Contracted Clinical Research Site
Toledo, Ohio · Recruiting
WB Contracted Clinical Research Site
Edmond, Oklahoma · Active not recruiting
WB Contracted Clinical Research Site
Pittsburgh, Pennsylvania · Active not recruiting
WB Contracted Clinical Research Site
Charleston, South Carolina · Active not recruiting
WB Contracted Clinical Research Site
Spartanburg, South Carolina · Active not recruiting
WB Contracted Clinical Research Site
Austin, Texas · Active not recruiting
WB Contracted Clinical Research Site
El Paso, Texas · Active not recruiting
WB Contracted Clinical Research Site
McKinney, Texas · Recruiting
WB Contracted Clinical Research Site
San Antonio, Texas · Active not recruiting
WB Contracted Clinical Research Site
Tyler, Texas · Active not recruiting
WB Contracted Clinical Research Site
Richmond, Virginia · Active not recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires F.D., Argentina · Active not recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires F.D., Argentina · Active not recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires F.D., Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires F.D., Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires F.D., Argentina · Active not recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires F.D., Argentina · Active not recruiting
WB Contracted Clinical Research Site
Córdoba, Córdoba Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Paraná, Entre Ríos Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Rosario, Santa Fe Province, Argentina · Active not recruiting
WB Contracted Clinical Research Site
Rosario, Santa Fe Province, Argentina · Active not recruiting
WB Contracted Clinical Research Site
Santa Fe, Santa Fe Province, Argentina · Recruiting
WB Contracted Clinical Research Site
San Miguel de Tucumán, Tucumán Province, Argentina · Active not recruiting
WB Contracted Clinical Research Site
San Miguel de Tucumán, Tucumán Province, Argentina · Active not recruiting
WB Contracted Clinical Research Site
San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Brookvale, New South Wales, Australia · Active not recruiting
WB Contracted Clinical Research Site
Coffs Harbour, New South Wales, Australia · Active not recruiting
WB Contracted Clinical Research Site
Maroubra, New South Wales, Australia · Active not recruiting
WB Contracted Clinical Research Site
Miranda, New South Wales, Australia · Active not recruiting
WB Contracted Clinical Research Site
Wollongong, New South Wales, Australia · Active not recruiting
Showing 40 of 73 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.